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Breast cancer frequently metastasises to
bone, with resultant bone destruction.
This destruction is probably mediated by
release of osteolytic substances from
tumour cells. Using in vitro organ culture
(Reynolds, 1968) we previously reported
that 23/38 primary human breast car-
cinomas showed significant osteolytic
activity (Powles et al., 1976) mediated, at
least in part, by prostaglandins (Dowsett
et al., 1976; Powles et al., 1973; Goodson
et al., 1974). Early clinical follow-up ap-
peared to indicate that patients whose
tumours produced the greatest in vitro
osteolytic activity had the greatest risk of
bone metastases (Powles et al., 1976).
In this study we have analysed the sur-
vival and disease-free survival of these
patients after a further 4 years' follow-up.
We have also tested medium from organ
cultures ofhuman primary breast tumours
for osteolytic activity and have analysed
survival (overall and disease-free) accord-
ing to the amount of activity.
Tumonr tissue. Breast tumours were
removed surgically and the excess fat and
connective tissue was dissected away.
Tumour was then cut into 1 to 2 mm3
fragments and was assayed for osteolytic
activity.
Concomitant culture.-Two-day-old mice
were injected with 45calcium chloride.
Two days later the mice were decapitated
and the frontoparietal bones were removed
and divided into equal halves. Each half
was placed on a stainless steel raft in
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5 ml of modified Bigger's medium (Flow
Laboratories) containing 500 heat-in-
activated rabbit serum (Wellcome) and
preincubated for 24 h at 37°C in an
atmosphere of 500 Co2 in air. The pre-
incubation medium was then replaced
with fresh medium and 15-20 mg of
breast tissue was placed on the raft 5 mm
from one ofthe bone halves, the other half
in a separate culture being used as a con-
trol. Four control and 4 tumour-treated
bones were used for each assay. After 3
days' further incubation the bone was
dissolved in hydrochloric acid and the
45Ca content of the medium and bone was
measured by scintillation counting. The
degree of tumour-induced osteolysis was
expressed as:
045Ca released from bone andtumour
045Ca released from control bone
x 100
Consecutive culture.-Tumour fragments
(15-20 mg/5 ml medium) were incubated
for 65 h in the absence of bone. This
medium was then membrane-filtered to
remove all cells and debris, and added to
bone cultures and incubated for 3 days
under the same conditions as above. Four
control and 4 test bones were used for
each assay. The degree of osteolysis was
expressed as a percentage of the control
value.
All patients were seen at the Royal
Marsden Hospital, Sutton, Surrey, where
they were regularly assessed for metastaticOSTEOLYTIC ACTIVITY OF BREAST TUMOUR TISSUE
TABLE.-Comparison of in vitro osteolysis 1.00
by two methods B
% Control osteolysis
Concomitant Consecutive 0.80
Patient culture culture
.. ;
1 118 152 ,
2 217 326
3 209 246 c 0.60
4 228 226
5 116 221 ,^
6 116 330 0
7 167 234
8 293 312 - 0.40
0
disease, clinically and with chest X-ray,
radiological skeletal survey, bone scan, 0.20_
liver scan, ultrasound and urine and
blood biochemistry.
Tumours from 8 patients were tested for L
osteolytic activity in concomitant and 0.00 20 40 60 80 100
consecutive cultures (Table). The results TIME (months)
obtained by the two methods for the same
tumour were dissimilar, as was the ranking
of the osteolytic activity of the different
tumours. The Wilcoxon sign rank test for
matched pairs was applied to these results
and a significant difference (P < 002) was 1.0-
found.
As previously reported (Powles et al., _,
1976), the osteolytic activity of38 tumours
in concomitant culture ranged from 0- z 0.80 .1..
192% above control values, with a mean
1.00 ...........
A -0.60X
0.80 -0.40
LiJ
Li. .........c
X 0.602 4
O ~~~~~~~~~~~~~~~~~~~TIME (mOnthS)
F ~~~~~~~~~~~~~FIG. 1.-On the basis of the in vitro osteolytic
c 0.20 activity of tumour biopsies in concomitant
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of 64% and a median of 51% greater than
control. Of the 38 patients, 2 have been
lost to follow-up. The remaining 36 have
been divided into two groups of 18, the
group whose tumours produced the most
in vitro osteolysis ("high" group) being
compared with the 18 with the least active
tumours ("low" group). The range of
values in the high group was 54-192%
above control, mean 109%, median 106%;
the low range was 0-48%, mean 17%
median 15.5%. Of the 18 patients in the
high group 14 (78%) developed metastases
(8 (44%) in bone) and 10 (56%) diedduring
the period of follow-up. In the "low"
group 9 (500o) developed metastases
(4 (22%) in bone) and 4 (22%) died. The
probability of bone metastases developing
was compared in the two groups (Fig. IA).
The apparent difference between the two
groups at 5 years is not significant (P=
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FIG. 2. On the basis of the in vitro osteolytic
activity of tumour biopsies in consecutive
culture (q.v.) 61 breast-cancer patients were
divided into a low group of 30 (.
and ahigh group of 31 ( ) for follow up.
A, Probability ofbone metastasis with time.
B, Probability of survival with time.
C, Probability of any metastasis with time.
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0.18) as the number of patients is small.
The probability of survival (Fig. 1B) is
the same in the two groups (P= 0.42) nor
is the probability of metastases at other
sites (Fig. IC) (P= 0.31).
Sixty-one carcinomas were assayed for
osteolytic activity in consecutive culture.
Values ranged from 8-249% above con-
trol, mean 78%, median 69%. Thirty-one
patients with the most osteolytically active
tumours (high group) were compared with
30 patients with less osteolytically active
tumours (lowgroup). The range ofvalues in
the high group was69-2490% above control,
with a mean of 116% and a median of
100%; in the low group the range was
8-680o, mean 39%0, median 37%o. None
were lost to follow up.
In the high group 15 (48%) developed
metastases (14 (45%) in bone) and 10
(32%) died, whereas in the low group 16
(53°0) developed metastases (13 (430o)
in bone) and 11 (370o) died. The analysis
of bone metastases, survival and meta-
stases at any site are shown in Fig. 2A,
B and C respectively and there is no
evidence from these data of any difference
between the two groups (P=0.98, 0*98
and 0 88 respectively).
We have previously reported (Powles
et al., 1976) a higher incidence of bone
metastases in patients whose tumour
showed high in vitro osteolytic activity by
hot concomitant culture method. The
longer follow-up in this study shows that
the apparent difference in the relapse and
survival rates seen in the first 20 months
was not maintained. This discrepancy is
probably partly due to the small number
of patients studied, and partly to the
complexity of the factors which may be
involved in metastasis.
Even though a variable degree of osteo-
lytic activity could be detected in the
medium from organ culture of most ofthe
61 breast tumours examined, there appears
to be no relationship between the activity
in the medium and development of meta-
stases or death in the patient.
In neither assay system was the tumour
allowed to come into direct contact with
bone, thus osteolysis was mediated by a
soluble factor in the incubation medium.
The percentage osteolysis found in the
consecutive assay was greater than that
seen in the concomitant culture, and there
was apparently norelationshipbetweenthe
osteolytic activity of the same tumours
when tested by the two methods. This
suggests that certain osteolytic factors
accumulated in the medium and remained
active, but the discrepancies between the
results obtained by the two methods with
the same tumours suggest that different
factors are responsible for the osteolysis
detected. This is in accord with the report
that in addition to osteolytic PGF and
PGE produced by tumours there are other
factors which are at least as important
(Dowsett et al., 1976). Histologicalevidence
suggests that bone invasion by metastatic
tumour depends initially on osteoclastic
activity and, in a second phase, on direct
bone destruction by tumour cells (Galasko,
1976).
This studyindicates that breast tumours
produce osteolytic substances which can
be detected in an in vitro system, but we
lhave been unable to establish any correla-
tion between the activity detected in vitro
and the subsequent behaviour of the
tumour in patients.
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